4 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and ... between SGLT-2 inhibitors ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes ... #cardiovascular
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Trials of SGLT2 inhibitors ... EMPA-REG OUTCOME - Empagliflozin ... DAPA-HF - Dapagliflozin ... EMPEROR-REDUCED - Empagliflozin ... #EBM #trial #visualabstract
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
Dapagliflozin in ... or death from cardiovascular ... or absence of diabetes ... #hfref #chf #visualabstract ... #ebm
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... that modulate sodium ... treatment of type II diabetes ... provide significant cardiovascular ... , #empagliflozin